These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 844063)

  • 41. Study of the clinical effectivity of Sanegyt.
    Dobi S; Siró B; Szabó T; Petrányi G
    Ther Hung; 1980; 28(2):60-6. PubMed ID: 7466717
    [No Abstract]   [Full Text] [Related]  

  • 42. Exercise, training, and hypertension.
    Tipton CM
    Exerc Sport Sci Rev; 1984; 12():245-306. PubMed ID: 6376135
    [No Abstract]   [Full Text] [Related]  

  • 43. [New antihypertensive drugs. II. Debrisoquin or Declinax].
    Amery A; Deruyttere M; Fagard R; Koninckx P
    Acta Clin Belg; 1970; 25(5):317-34. PubMed ID: 5513889
    [No Abstract]   [Full Text] [Related]  

  • 44. Changes in the functional state of left ventricle myocardium in hypertensive disease after treatment with hypotensors.
    Beloev Y; Rashev M; Katoyanova A
    Nauchni Tr Vissh Med Inst Sofiia; 1968; 47(2):49-56. PubMed ID: 4240146
    [No Abstract]   [Full Text] [Related]  

  • 45. [Hypertension and sports].
    Rost R
    Dtsch Med Wochenschr; 1987 May; 112(20):815-7. PubMed ID: 3552556
    [No Abstract]   [Full Text] [Related]  

  • 46. [Comparative evaluation of the therapeutic effect and mechanism of action of isobarin and aldomet in hypertension].
    Erina EV; Zamyslova KN; Il'ina LI; Glezer GA; Pershakova LP; Vyshnepol'skiĭ IuIa; Labeeva TN
    Kardiologiia; 1967 Mar; 7(3):35-41. PubMed ID: 4883577
    [No Abstract]   [Full Text] [Related]  

  • 47. Evaluation of pindolol in the treatment of hypertension.
    Sedgwick JP; Crowder D
    Curr Med Res Opin; 1975; 3(2):89-94. PubMed ID: 1095311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Study of blood pressure response to exertion in essential hypertension. Its modification with anti-hypertensive treatment].
    Soria Arcos F; Alegría Ezquerra E; Valdés Chávarri M; García Alberola A; Vicente Vera T; Pérez Lorente F; Apellaniz Sáinz-Trápaga G
    Rev Clin Esp; 1991 Mar; 188(5):237-41. PubMed ID: 1788456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The risk factor hypertension (author's transl)].
    Scheler F
    Offentl Gesundheitswes; 1977 Apr; 39(4):189-95. PubMed ID: 140349
    [No Abstract]   [Full Text] [Related]  

  • 50. [Action of digitalis on beta blockade-induced hemodynamic changes in patients with hypertension].
    Nechwatal W; Isbary J; Greding H; König E
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():221-2. PubMed ID: 613581
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of physical exercise on high blood pressure.
    Lund-Johansen P
    Contrib Nephrol; 1982; 30():98-100. PubMed ID: 7116868
    [No Abstract]   [Full Text] [Related]  

  • 52. [Evaluation of a pyridopyridazine as a drug with marked antihypertensive properties (author's transl)].
    Lehmann HU; Witt E; Hochrein H
    Med Klin; 1977 Jul; 72(28-29):1203-8. PubMed ID: 887046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is drug treatment indicated for mild hypertension with diastolic blood pressure of 90 mmHg to 100 mmHg? An opposing view.
    Aagaard GN
    J Fam Pract; 1988 Apr; 26(4):455-9. PubMed ID: 3282029
    [No Abstract]   [Full Text] [Related]  

  • 54. Observations on the hypotensive action of "Catapres" (ST 155) in man.
    Barnett AJ; Cantor S
    Med J Aust; 1968 Jan; 1(3):87-91. PubMed ID: 4867515
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of guanadrel and guanethidine.
    Hansson L; Pascual A; Julius S
    Clin Pharmacol Ther; 1973; 14(2):204-8. PubMed ID: 4571980
    [No Abstract]   [Full Text] [Related]  

  • 56. [The antihypertensive effect of Uncaria rhynchophylla in essential hypertension (author's transl)].
    Wu CC; Chang CC; Chen RL
    Taiwan Yi Xue Hui Za Zhi; 1980 Sep; 79(9):749-52. PubMed ID: 6939788
    [No Abstract]   [Full Text] [Related]  

  • 57. [Variants of hemodynamic reactions to the calcium antagonist finoptin in patients with hypertension].
    Goloshchapov OA; Goldabin VI
    Kardiologiia; 1990 Dec; 30(12):63-4. PubMed ID: 2097402
    [No Abstract]   [Full Text] [Related]  

  • 58. Letter: Debrisoquine, guanethidine, and bethanidine in hypertension.
    Talbot S; O'Malley BC; Bing RH
    Br Med J; 1975 May; 2(5965):278. PubMed ID: 1131592
    [No Abstract]   [Full Text] [Related]  

  • 59. Physical exercise and antihypertensive drugs.
    Rost R
    Nephron; 1987; 47 Suppl 1():27-9. PubMed ID: 3696346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pindolol in the treatment of hypertension: systolic time intervals as a predictor of response to beta receptor blockade.
    Plotnick GD; Fisher ML; Hamilton JH; Robinson M; Carliner NH; Janowski AH; Hamilton BP
    Am J Cardiol; 1980 Mar; 45(3):614-20. PubMed ID: 6243851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.